DIG
BMRN icon

DeepCurrents Investment Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

DeepCurrents Investment Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-51,249
Closed -$3.37M – 185
2024
Q4 		$3.37M Sell
51,249
-20,486
-29% -$1.37M 0.11% 118
2024
Q3 		$5.04M Sell
71,735
-45,447
-39% -$3.8M 0.15% 115
2024
Q2 		$9.65M Sell
117,182
-18,166
-13% -$1.51M 0.38% 81
2024
Q1 		$11.8M Sell
135,348
-17,836
-12% -$1.6M 0.46% 68
2023
Q4 		$14.8M Buy
153,184
+5,047
+3% +$446K 0.54% 63
2023
Q3 		$13.1M Buy
148,137
+4,329
+3% +$385K 0.57% 62
2023
Q2 		$12.5M Sell
143,808
-49,925
-26% -$4.7M 0.49% 61
2023
Q1 		$18.8M Buy
193,733
+6,297
+3% +$653K 0.73% 43
2022
Q4 		$19.4M Buy
187,436
+12,053
+7% +$1.13M 0.75% 41
2022
Q3 		$14.9M Buy
175,383
+16,312
+10% +$1.45M 0.57% 59
2022
Q2 		$13.2M Buy
159,071
+28,216
+22% +$2.25M 0.53% 61
2022
Q1 		$10.1M Buy
+130,855
New +$10.9M 0.31% 74
2020
Q2 		– Sell
-63,460
Closed -$6.31M – 126
2020
Q1 		$5.36M Sell
63,460
-12,017
-16% -$1.04M 0.26% 66
2019
Q4 		$6.38M Buy
75,477
+42,986
+132% +$3.25M 0.29% 56
2019
Q3 		$2.19M Sell
32,491
-14,110
-30% -$1.09M 0.15% 65
2019
Q2 		$3.99M Sell
46,601
-17,617
-27% -$1.51M 0.34% 60
2019
Q1 		$5.7M Sell
64,218
-80,591
-56% -$7.47M 0.49% 46
2018
Q4 		$12.3M Buy
+144,809
New +$13.8M 1.53% 21

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DeepCurrents Investment Group's BMRN Position: Q1 2025 in Review

DeepCurrents Investment Group sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2025, closing a stake of 51,249 shares — an estimated $3.37M sold.

DeepCurrents Investment Group first reported a position in BMRN in Q4 2018 and held it in 18 quarters. The position peaked at $19.4M in Q4 2022. 584 funds tracked by Wall St. Rank hold BMRN as of Q1 2025.

  • DeepCurrents Investment Group reported no remaining BioMarin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • DeepCurrents Investment Group sold 51,249 BioMarin Pharmaceuticals shares in Q1 2025, an estimated $3.37M.
  • DeepCurrents Investment Group first reported a position in BioMarin Pharmaceuticals in Q4 2018 and held it in 18 quarters.
  • DeepCurrents Investment Group's BioMarin Pharmaceuticals position peaked at $19.4M in Q4 2022.
  • 584 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2025.

Based on DeepCurrents Investment Group's 13F filing for Q1 2025, filed 15 May 2025.